🇺🇸 Yellow fever vaccine (live) in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Condition Aggravated — 1 report (10%)
- Contraindicated Product Administered — 1 report (10%)
- Diarrhoea — 1 report (10%)
- Drug Effect Decreased — 1 report (10%)
- Faeces Hard — 1 report (10%)
- Flatulence — 1 report (10%)
- Gastrooesophageal Reflux Disease — 1 report (10%)
- Micturition Urgency — 1 report (10%)
- Pollakiuria — 1 report (10%)
- Urinary Retention — 1 report (10%)
Other Immunology approved in United States
Frequently asked questions
Is Yellow fever vaccine (live) approved in United States?
Yellow fever vaccine (live) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Yellow fever vaccine (live) in United States?
Sanofi Pasteur, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.